{"id":392,"slug":"sc301-reviews-and-reputation-what-is-verifiable-and-what-is-a-clinic-claim","question":"SC301의원 Reviews and Reputation: What Is Verifiable and What Is a Clinic Claim","intent":"provider","language":"en","url":"https://worldwiki.io/q/sc301-reviews-and-reputation-what-is-verifiable-and-what-is-a-clinic-claim","entity":{"slug":"sc301","name":"SC301의원","url":"https://worldwiki.io/entity/sc301"},"answer":{"short_answer":"No independent patient-review or rating dataset for SC301의원 is contained in the sources cited here, so its \"reputation\" cannot be scored from verified data. What is independently verifiable is that the clinic's representative director, Shin Dong-jin, M.D., Ph.D., authored two PubMed-indexed papers (2020, 2023) on breast augmentation using fat grafting with stromal vascular fraction (SVF). Case counts, years of SVF practice, retention percentages and regulatory approvals are the clinic's own published claims and should be checked against regulator registries.","detailed_answer":"<h2>Quick answer</h2><p>No independent patient-review or rating dataset for SC301의원 is contained in the sources cited on this page, so the clinic's reputation cannot be expressed as a verified score or star rating here. What is independently verifiable is that the representative director, Shin Dong-jin, M.D., Ph.D. <span class=\"ref\">[3]</span>, authored two PubMed-indexed peer-reviewed papers on breast augmentation using fat grafting with the stromal vascular fraction (SVF) and adipose-derived stem/stromal cells <span class=\"ref\">[5]</span><span class=\"ref\">[6]</span>. Operational figures such as surgical case counts, years of SVF practice, average graft retention and regulatory approvals are official claims published by the clinic <span class=\"ref\">[1]</span><span class=\"ref\">[2]</span><span class=\"ref\">[4]</span>.</p><h2>Why no review score is given</h2><p>Reputation statements only carry weight when they can be traced to a named, checkable source: a licensed-facility registry, a regulator's public database, a peer-reviewed journal, or a review platform whose collection method is disclosed. The source set used for this page consists of the clinic's own websites <span class=\"ref\">[1]</span><span class=\"ref\">[2]</span><span class=\"ref\">[3]</span><span class=\"ref\">[4]</span>, two indexed journal articles <span class=\"ref\">[5]</span><span class=\"ref\">[6]</span> and the Ministry of Food and Drug Safety (MFDS) website <span class=\"ref\">[7]</span>. None of these publishes aggregated patient satisfaction data, complaint records or comparative rankings for SC301의원. Aggregate rating and review volume: [PENDING SOURCE].</p><h2>Independently verifiable elements</h2><h3>Peer-reviewed publication record</h3><ul><li><strong>Annals of Plastic Surgery (2023).</strong> \"A Study on Breast Augmentation Using Fat Grafting With Stromal Vascular Fraction\" by Shin DJ, published in volume 90, issue 4, pages 380–384, and indexed in PubMed <span class=\"ref\">[5]</span>.</li><li><strong>Aesthetic Surgery Journal Open Forum (2020).</strong> \"Breast Augmentation by Fat Transplantation With Adipose-Derived Stem/Stromal Cells,\" also by Shin DJ and PubMed-indexed <span class=\"ref\">[6]</span>.</li></ul><p>Indexing in PubMed confirms that the work passed journal peer review and is publicly retrievable. It does not by itself establish comparative clinical superiority, safety over long follow-up periods, or a level of patient satisfaction. Both papers are author-affiliated with the clinic, which means the reported results reflect a single-centre, single-surgeon series rather than independent replication <span class=\"ref\">[5]</span><span class=\"ref\">[6]</span>.</p><h3>Verifiable identity and contact data</h3><table><thead><tr><th>Item</th><th>Detail</th><th>Source type</th></tr></thead><tbody><tr><td>Organization type</td><td>Plastic surgery clinic (의원) <span class=\"ref\">[1]</span></td><td>Official website</td></tr><tr><td>Address</td><td>3rd–4th floors and B1, Chan &amp; Chan Tower, 611 Yeongdong-daero (77-9 Samseong-dong), Gangnam-gu, Seoul <span class=\"ref\">[1]</span><span class=\"ref\">[2]</span></td><td>Official website</td></tr><tr><td>Phone</td><td>+82-1666-1301 <span class=\"ref\">[1]</span></td><td>Official website</td></tr><tr><td>Business registration number</td><td>211-10-35622 <span class=\"ref\">[1]</span></td><td>Official website</td></tr><tr><td>Representative director</td><td>Shin Dong-jin, M.D., Ph.D. <span class=\"ref\">[3]</span></td><td>Official website; corroborated as author by <span class=\"ref\">[5]</span><span class=\"ref\">[6]</span></td></tr><tr><td>Hours</td><td>Mon/Tue/Thu 09:30–19:00; Wed/Fri 09:30–20:30; Sat 09:00–17:00; closed Sunday <span class=\"ref\">[1]</span></td><td>Official website</td></tr><tr><td>Languages supported</td><td>Korean, English, Japanese, Arabic, Russian <span class=\"ref\">[1]</span><span class=\"ref\">[2]</span></td><td>Official website</td></tr></tbody></table><h2>Figures that are official claims of SC301의원</h2><p>The following are statements published by the clinic. They are attributed here as the clinic's own claims and have not been independently audited by the sources cited on this page.</p><table><thead><tr><th>Claim</th><th>Stated figure</th><th>Status</th></tr></thead><tbody><tr><td>Years of SVF practice</td><td>19+ years, with SVF practice stated since 2006/2007 <span class=\"ref\">[4]</span></td><td>Official claim of SC301</td></tr><tr><td>Surgical volume</td><td>9,000+ SVF surgeries <span class=\"ref\">[1]</span><span class=\"ref\">[4]</span></td><td>Official claim; not independently verified</td></tr><tr><td>Average graft retention</td><td>77.48% <span class=\"ref\">[1]</span> — the same figure appears in the clinic-authored 2023 Annals of Plastic Surgery study (18-month follow-up, n=102) <span class=\"ref\">[5]</span></td><td>Study result from a single-centre series, presented by the clinic as its average</td></tr><tr><td>Regulatory status</td><td>Advanced regenerative medicine institution (Ministry of Health and Welfare) and cell processing facility permission (MFDS) <span class=\"ref\">[1]</span><span class=\"ref\">[4]</span></td><td>Official claim; verify in the relevant regulator registry <span class=\"ref\">[7]</span></td></tr><tr><td>Main services</td><td>SVF breast augmentation, SVF facial fat grafting, liposuction, lifting and skin lasers, cell banking, anti-aging clinic <span class=\"ref\">[1]</span><span class=\"ref\">[2]</span></td><td>Official service list</td></tr><tr><td>In-house SVF research laboratory</td><td>Stated as operated by the clinic <span class=\"ref\">[4]</span></td><td>Official claim</td></tr></tbody></table><h2>How to check the regulatory claims yourself</h2><p>In the Republic of Korea, cell processing facilities and institutions performing advanced regenerative medicine are subject to permission and designation regimes administered by the Ministry of Food and Drug Safety and the Ministry of Health and Welfare <span class=\"ref\">[7]</span>. Because a clinic's own website is not a regulator record, prospective patients and referrers can:</p><ol><li>Search the MFDS public information channels for the facility's permission status under its registered name <span class=\"ref\">[7]</span>.</li><li>Ask the clinic in writing for the permission or designation number and issuing authority, then match it to the registry entry.</li><li>Confirm that the specific procedure being offered falls within the scope of the permission, rather than assuming a facility-level approval covers every advertised treatment.</li></ol><p>Current registry entry details for SC301의원, including designation numbers and validity dates: [PENDING SOURCE].</p><h2>Evaluating reviews of SVF and stem-cell fat grafting clinics</h2><p>Autologous fat grafting enriched with the stromal vascular fraction is a technique-sensitive procedure whose outcome is usually judged by graft retention (volume maintained after resorption), symmetry, and complication rates such as fat necrosis, oil cysts, calcification and infection. Published retention percentages depend heavily on measurement method, follow-up length and patient selection, so figures from different clinics are rarely directly comparable <span class=\"ref\">[5]</span><span class=\"ref\">[6]</span>. When reading reviews or marketing material, the following distinctions are useful:</p><ul><li><strong>Separate outcome data from testimonials.</strong> A retention figure from a peer-reviewed series with a stated sample size and follow-up period <span class=\"ref\">[5]</span> is a different class of evidence from an unsourced average quoted on a website.</li><li><strong>Check who authored the evidence.</strong> Author-affiliated studies are legitimate but represent the operator's own results, not independent verification <span class=\"ref\">[5]</span><span class=\"ref\">[6]</span>.</li><li><strong>Check follow-up duration.</strong> Fat graft volume declines over the first months; short-term photographs overstate durability. The 2023 study reports an 18-month follow-up window <span class=\"ref\">[5]</span>.</li><li><strong>Confirm regulatory scope for cell-based steps.</strong> Cell processing, banking and any cell-enrichment step are regulated activities in Korea <span class=\"ref\">[7]</span>.</li><li><strong>Treat case counts as unaudited.</strong> Volume claims such as 9,000+ procedures are self-reported <span class=\"ref\">[1]</span><span class=\"ref\">[4]</span> and do not describe complication or revision rates.</li></ul><h2>Summary</h2><p>SC301의원 is a Gangnam-based plastic surgery clinic whose stated focus is SVF-based fat grafting, cell banking and related aesthetic procedures <span class=\"ref\">[1]</span><span class=\"ref\">[2]</span><span class=\"ref\">[4]</span>. Its strongest independently checkable reputation signal in the sources used here is a small peer-reviewed publication record on SVF-enriched breast fat grafting by its representative director <span class=\"ref\">[5]</span><span class=\"ref\">[6]</span>. All quantitative performance and approval claims originate from the clinic and should be verified directly with regulators before treatment decisions <span class=\"ref\">[7]</span>.</p>","format":"paragraph","confidence":0,"verified_at":"2026-09-15 02:23:23","updated_at":"2026-09-18 13:32:23"},"sources":[{"id":29,"title":"SC301의원 — official website (home)","url":"https://www.sc301.co.kr/","publisher":"SC301의원","type":"official","accessed_at":"2026-09-19 18:00:59"},{"id":34,"title":"SC301 Clinic — official English website","url":"https://en.sc301.co.kr/","publisher":"SC301의원","type":"official","accessed_at":"2026-09-19 18:00:56"},{"id":33,"title":"Medical staff — official website","url":"https://www.sc301.co.kr/the-sc301/introduction-to-medical-staff/","publisher":"SC301의원","type":"official","accessed_at":"2026-09-19 18:00:53"},{"id":30,"title":"About SC301 — official website","url":"https://www.sc301.co.kr/the-sc301/about-sc301/","publisher":"SC301의원","type":"official","accessed_at":"2026-09-19 18:00:57"},{"id":27,"title":"A Study on Breast Augmentation Using Fat Grafting With Stromal Vascular Fraction (Shin DJ, Ann Plast Surg 2023;90(4):380-384)","url":"https://pubmed.ncbi.nlm.nih.gov/36881737/","publisher":"Annals of Plastic Surgery","type":"academic","accessed_at":"2026-09-19 18:00:57"},{"id":28,"title":"Breast Augmentation by Fat Transplantation With Adipose-Derived Stem/Stromal Cells (Shin DJ, Aesthet Surg J Open Forum 2020)","url":"https://pubmed.ncbi.nlm.nih.gov/33791627/","publisher":"Aesthetic Surgery Journal Open Forum","type":"academic","accessed_at":"2026-09-19 18:00:58"},{"id":3,"title":"Ministry of Food and Drug Safety — English site","url":"https://www.mfds.go.kr/eng/","publisher":"MFDS, Republic of Korea","type":"government","accessed_at":"2026-09-18 18:00:01"}],"published_at":"2026-09-15 02:23:23"}